114 related articles for article (PubMed ID: 36752344)
21. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
[TBL] [Abstract][Full Text] [Related]
22. Endogenous liver carcinogenesis in the rat.
Nakae D
Pathol Int; 1999 Dec; 49(12):1028-42. PubMed ID: 10632923
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.
Rao A; van de Peppel IP; Gumber S; Karpen SJ; Dawson PA
Front Med (Lausanne); 2020; 7():60. PubMed ID: 32158763
[TBL] [Abstract][Full Text] [Related]
24. A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator.
Zheng X; Jia Y; Qiu L; Zeng X; Xu L; Wei M; Huang C; Liu C; Chen L; Han J
J Biol Chem; 2020 Feb; 295(6):1474-1488. PubMed ID: 31914406
[TBL] [Abstract][Full Text] [Related]
25. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
Lou L; Chen YX; Jin L; Li X; Tao X; Zhu J; Chen X; Wu S; Ye W; He J; Ding G
J Int Med Res; 2013 Feb; 41(1):55-63. PubMed ID: 23569130
[TBL] [Abstract][Full Text] [Related]
27. HCC development is associated to peripheral insulin resistance in a mouse model of NASH.
De Minicis S; Agostinelli L; Rychlicki C; Sorice GP; Saccomanno S; Candelaresi C; Giaccari A; Trozzi L; Pierantonelli I; Mingarelli E; Marzioni M; Muscogiuri G; Gaggini M; Benedetti A; Gastaldelli A; Guido M; Svegliati-Baroni G
PLoS One; 2014; 9(5):e97136. PubMed ID: 24853141
[TBL] [Abstract][Full Text] [Related]
28. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors.
Obo Y; Yamada T; Furukawa M; Hotta M; Honoki K; Fukushima N; Tsujiuchi T
Mutat Res; 2009 Jan; 660(1-2):47-50. PubMed ID: 19000703
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
[TBL] [Abstract][Full Text] [Related]
30. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.
Afonso MB; Rodrigues PM; Mateus-Pinheiro M; Simão AL; Gaspar MM; Majdi A; Arretxe E; Alonso C; Santos-Laso A; Jimenez-Agüero R; Eizaguirre E; Bujanda L; Pareja MJ; Banales JM; Ratziu V; Gautheron J; Castro RE; Rodrigues CMP
Gut; 2021 Dec; 70(12):2359-2372. PubMed ID: 33361348
[TBL] [Abstract][Full Text] [Related]
31. Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.
Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Sharma A; Ranvir R; Kadam S; Ingale K; Patel H; Nyska A; Jain MR
BMC Cancer; 2023 Jan; 23(1):59. PubMed ID: 36650455
[TBL] [Abstract][Full Text] [Related]
32. Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
Kanamori H; Nakade Y; Yamauchi T; Sakamoto K; Inoue T; Yamamoto T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sumida Y; Nakao H; Fukuzawa Y; Yoneda M
PLoS One; 2017; 12(6):e0180475. PubMed ID: 28662136
[TBL] [Abstract][Full Text] [Related]
33. High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats.
Nakae D; Yoshiji H; Mizumoto Y; Horiguchi K; Shiraiwa K; Tamura K; Denda A; Konishi Y
Cancer Res; 1992 Sep; 52(18):5042-5. PubMed ID: 1516060
[TBL] [Abstract][Full Text] [Related]
34. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
[TBL] [Abstract][Full Text] [Related]
35. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet.
Nakanishi C; Moriuchi A; Ido A; Numata M; Kim ID; Kusumoto K; Hasuike S; Abe H; Nagata K; Akiyama Y; Uto H; Kataoka H; Tsubouchi H
Oncol Rep; 2006 Jul; 16(1):25-31. PubMed ID: 16786119
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of hepatocarcinogenesis initiated with diethylnitrosamine or N-nitrosobis(2-hydroxypropyl)amine by a choline-deficient, L-amino acid-defined diet administered prior to the carcinogen exposure in rats.
Kishida H; Nakae D; Kobayashi Y; Kusuoka O; Kitayama W; Denda A; Fukui H; Konishi Y
Exp Toxicol Pathol; 2000 Oct; 52(5):405-12. PubMed ID: 11089891
[TBL] [Abstract][Full Text] [Related]
37. Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Kessler SM; Simon Y; Gemperlein K; Gianmoena K; Cadenas C; Zimmer V; Pokorny J; Barghash A; Helms V; van Rooijen N; Bohle RM; Lammert F; Hengstler JG; Mueller R; Haybaeck J; Kiemer AK
Int J Mol Sci; 2014 Apr; 15(4):5762-73. PubMed ID: 24714086
[TBL] [Abstract][Full Text] [Related]
38. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells.
Onaga M; Ido A; Hasuike S; Uto H; Moriuchi A; Nagata K; Hori T; Hayash K; Tsubouchi H
J Hepatol; 2003 Nov; 39(5):779-85. PubMed ID: 14568261
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma associated lipid metabolism reprogramming.
Skill NJ; Scott RE; Wu J; Maluccio MA
J Surg Res; 2011 Jul; 169(1):51-6. PubMed ID: 19932908
[TBL] [Abstract][Full Text] [Related]
40. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
